The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer

di Naqash, Abdul Rafeh, Kihn-Alarcón, Alba J., Stavraka, Chara, Kerrigan, Kathleen, Maleki Vareki, Saman, Pinato, David James, Puri, Sonam
Pubblicato in Ann Transl Med (2021)

Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options

di Personeni, Nicola, Lleo, Ana, Pressiani, Tiziana, Colapietro, Francesca, Openshaw, Mark Robert, Stavraka, Chara, Pouptsis, Athanasios, Pinato, David James, Rimassa, Lorenza
Pubblicato in Cancers (Basel) (2020)

Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

di Yen, Clarence, Sharma, Rohini, Rimassa, Lorenza, Arizumi, Tadaaki, Bettinger, Dominik, Choo, Huay Yee, Pressiani, Tiziana, Burlone, Michela E., Pirisi, Mario, Giordano, Laura, Abdulrahman, Anisa, Kudo, Masatoshi, Thimme, Robert, Park, Joong Won, Pinato, David James
Pubblicato in Liver Cancer (2017)

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

di Cortellini, Alessio, Tucci, Marco, Adamo, Vincenzo, Stucci, Luigia Stefania, Russo, Alessandro, Tanda, Enrica Teresa, Spagnolo, Francesco, Rastelli, Francesca, Bisonni, Renato, Santini, Daniele, Russano, Marco, Anesi, Cecilia, Giusti, Raffaele, Filetti, Marco, Marchetti, Paolo, Botticelli, Andrea, Gelibter, Alain, Occhipinti, Mario Alberto, Marconcini, Riccardo, Vitale, Maria Giuseppa, Nicolardi, Linda, Chiari, Rita, Bareggi, Claudia, Nigro, Olga, Tuzi, Alessandro, De Tursi, Michele, Petragnani, Nicola, Pala, Laura, Bracarda, Sergio, Macrini, Serena, Inno, Alessandro, Zoratto, Federica, Veltri, Enzo, Di Cocco, Barbara, Mallardo, Domenico, Vitale, Maria Grazia, Pinato, David James, Porzio, Giampiero, Ficorella, Corrado, Ascierto, Paolo Antonio
Pubblicato in J Immunother Cancer (2020)